Novo Nordisk says diabetes drug Victoza superior to Merck rival

COPENHAGEN (Reuters) – Danish Novo Nordisk, the world’s biggest insulin producer, said on Friday it had received a product label update for diabetes drug Victoza to include data showing superior efficacy when compared with rival drug Januvia from Merck.


Reuters: Health News